HIF-1α is therefore the likely factor that induces neoangiogenesis as a very early consequence of VHL gene mutation in human renal tubular cells, ensuring that pre-tumourigenic VHL mutant cells will have an adequate blood supply that will presumably support them during the earliest stages of tumour development. The gene discussed is HIF1A; the disease is neoplasm.